KOSDAQBiotech & Pharma450330

Hass

₩3,850▼ 0.65%2026-11-18 close
Market Cap
₩31.5B
Turnover
₩14,873,935
Volume
3.9K
Shares out.
8.2M
PER
—
PBR
0.8×
EPS
-₩117
Dividend Yield
1.52%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩60 per share · Prices as of the 2026-11-18 close

01

Report overview

Sales Edged Up, Profit Fell, and Three Straight Quarterly Losses

Hass's annual sales rose modestly over 2023 to 2025, but operating profit and profit attributable to owners declined, and the company has posted operating losses in each quarter from Q1 2026 through Q3 2026.

  1. 1

    Annual sales rose from KRW 16 billion in 2023 to KRW 16.6 billion in 2025, while the operating margin fell from 10.1% to 5.4% over the same period.

  2. 2

    The company has recorded operating losses in three consecutive quarters from Q1 2026 to Q3 2026, and the net loss attributable to owners over the last four quarters totals KRW 896 million.

  3. 3

    Media reports said first-half 2026 sales fell about 6.4% from a year earlier to about KRW 7.4 billion, with delayed talks to expand business with a major North American distributor cited as a factor.

  4. 4

    Shareholders approved a cash dividend at the March 2026 annual meeting, and in August 2026 the company agreed to a share buyback trust contract worth KRW 1 billion.

  5. 5

    Exports accounted for 91.7% of sales in 2023, so overseas distribution channels weigh heavily on both revenue and profit.

02

Business structure

Hass is a dental restorative materials maker whose core technology fuses crystallized glass with zirconia into composite materials. It supplies its own Amber and Rosetta branded products to more than 70 countries, and exports accounted for 91.7% of sales in 2023.

The 2023 sales mix was lithium disilicate restorative materials at 68.6%, zirconia primary-tooth crowns at 19.7%, zirconia restorative materials traded as merchandise at 8.7%, investment materials at 2.3%, and other sales at 0.7%.

A data aggregator's breakdown for the second quarter of 2026 showed Amber Block at 21%, Rosetta Block at 20%, merchandise at 19%, Rosetta Ingot at 17% and Amber Ingot at 12%. That breakdown uses a different product classification from the 2023 data, so the two cannot be compared directly.

The Amber Dry Mill was launched in Korea in July 2026, and the company said it could help the business move past a growth stall. In overseas markets, expanding business with a major North American distributor is the key variable reported in the press.

Competition in the global dental materials market depends on proving differentiated quality. The company is also developing 3D printing resin, metal-composite 3D printing and crystallized glass 3D printing as new growth areas.

A national project to localize core semiconductor packaging materials began in July 2024, runs for 54 months and carries government funding of KRW 2.75 billion.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩4.8B₩300M6.3%
2025Q4₩3.8B₩300M8.6%
2026Q1₩3.3B-₩800M−24.6%
2026Q2₩4.1B-₩600M−14.9%
2026Q3₩3.5B-₩700M−19.1%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2023₩16B₩1.6B₩1.8B10.1%11.9%92.6%
2024₩16.2B₩1.2B₩1.8B7.7%3.9%20.7%
2025₩16.6B₩900M₩1.5B5.4%3.3%18.3%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-14

04

Earnings analysis

Annual sales moved from KRW 16 billion in 2023 to KRW 16.2 billion in 2024 (up 0.8% year on year) and KRW 16.6 billion in 2025 (up 2.6%), rising two years in a row from 2024 through 2025, with 2025 the largest year of the 2023 to 2025 span.

Operating profit fell from KRW 1.61 billion in 2023 to KRW 1.24 billion in 2024 (down 23.3%) and KRW 903 million in 2025 (down 27.1%), declining two years in a row from 2024 through 2025, with 2025 the smallest year.

The operating margin dropped from 10.1% to 7.7% and then 5.4%, so margins compressed even as sales grew. The company attributed the operating profit decline to higher costs from expanded new investment.

Profit attributable to owners was KRW 1.8 billion in 2023, KRW 1.79 billion in 2024 (down 0.2%) and KRW 1.55 billion in 2025 (down 13.6%). Net income including non-controlling interests was reported at the same levels for those years, so it followed the same path as profit attributable to owners.

Operating cash flow was KRW 1.5 billion in 2023, KRW 1.15 billion in 2024 and KRW 1.82 billion in 2025, rising in 2025. The debt ratio fell from 92.6% in 2023 to 20.7% in 2024 and 18.3% in 2025, when total liabilities were KRW 8.47 billion and total equity was KRW 46.4 billion.

Quarterly results show sales of KRW 4.83 billion and operating profit of KRW 305 million in Q3 2025, followed by sales of KRW 3.82 billion in Q4 2025 (down 21.0% from the prior quarter) but operating profit of KRW 330 million and profit attributable to owners of KRW 1.02 billion (up 230.3% from the prior quarter).

Q1 2026 sales were KRW 3.32 billion with an operating loss of KRW 818 million and a net loss attributable to owners of KRW 901 million, a swing to loss.

Q2 2026 sales recovered to KRW 4.12 billion (up 24.1% from the prior quarter), but the operating loss was KRW 615 million and the net loss attributable to owners was KRW 580 million.

Q3 2026 sales were KRW 3.48 billion (down 15.4% from the prior quarter and down 27.9% year on year), and the operating loss widened to KRW 666 million, while the net loss attributable to owners narrowed to KRW 431 million.

A press report on first-half 2026 results, with sales of about KRW 7.4 billion and an operating loss of about KRW 1.4 billion, cited delayed talks with a major North American distributor and new product development costs as drags on profitability.

The company has posted operating losses in three consecutive quarters from Q1 2026 to Q3 2026, and the net loss attributable to owners over the last four quarters totals KRW 896 million.

05

Industry analysis

Dental restorative materials are tied to global demand for prosthetic dental treatment, and with exports at 91.7% of sales in 2023, Hass is heavily exposed to overseas distribution conditions.

At the time of its registration statement, the company was classified in the medical devices industry, while the sector label on this platform is biopharmaceuticals and pharmaceuticals. In competition, the global dental materials market has been described in the press as one where quality differentiation matters.

On the cycle, Hass's sales moved only modestly over 2023 to 2025, from KRW 16 billion to KRW 16.6 billion, and reports in the first half of 2026 raised concerns about a year-on-year decline.

In North American distribution, delayed talks to expand business with a major distributor were reported as weighing on first-half 2026 results. In Korea, management pointed to the reception of the Amber Dry Mill, launched in July 2026, as a factor in whether the company escapes its growth stall.

In semiconductor packaging, the company said it aims to secure a foothold in the semiconductor glass interposer market and in PCB replacement markets for mobile devices and 5G and 6G equipment.

In optical materials, development results were shared for localizing optical components for extreme ultraviolet inspection equipment.

In short, quality competitiveness in dental materials and the expansion of overseas distribution channels are the two factors that set the company's position against the industry backdrop.

06

Outlook

In press reports on first-half 2026 results, delayed talks to expand business with a major North American distributor were cited as the key variable. The company said the Amber Dry Mill, launched in Korea in July 2026, could help it move past its growth stall on the back of interest in the dental market.

New product development costs were reported as reflected in 2026 results, which is part of the background to the operating losses from Q1 to Q3 2026.

On August 11, 2026, the board approved a share buyback trust contract worth KRW 1 billion with NH Investment & Securities, and on August 12 the company said the purpose was to stabilize the share price and reward employees.

At the annual shareholder meeting on March 26, 2026, the 18th fiscal year financial statements were approved and a cash dividend was resolved.

The national project to localize core semiconductor packaging materials is planned to run for 54 months from July 2024, with the goal of securing a foothold in the semiconductor glass interposer market.

On optical materials, results from the development project for optical components used in extreme ultraviolet inspection equipment were shared. The next periodic report is the 2026 annual report, which will disclose fourth-quarter 2026 sales and operating results. The next checkpoint is whether the Q4 2026 operating loss improves from the Q3 2026 level of KRW 666 million.

07

Valuation

PER
—
PBR
0.8×
ROE
-2.1%
EPS
-₩117
BPS
₩5,187
Dividend per share
₩60

Hass's price-to-book ratio sits below 1x, meaning the share price is low relative to total equity. Of the KRW 46.4 billion in total equity at the end of 2025, the equity attributable to owners is KRW 46.4 billion, and total liabilities of KRW 8.47 billion produce a debt ratio of 18.3%.

Because the company has posted net losses over the last four quarters, an earnings-based price-to-earnings ratio cannot be calculated. A cash dividend was approved at the March 2026 annual meeting, but how far dividends can be sustained relative to earnings depends on whether profit recovers.

The operating margin declined from 10.1% in 2023 to 5.4% in 2025, and operating losses continued through Q3 2026. Asset-based and earnings-based measures therefore point in different directions. As a small-cap stock, its multiples can move sharply with changes in the share price.

Taken together with several years of declining profit and the 2026 loss trend, the range of interpretation for valuation depends on whether earnings recover.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-14

08

Bull factors

Lower Debt Burden and Financial Base

The debt ratio fell from 92.6% in 2023 to 18.3% in 2025, with total liabilities of KRW 8.47 billion and total equity of KRW 46.4 billion at the end of 2025. Operating cash flow also rose to KRW 1.82 billion in 2025 from KRW 1.15 billion in 2024. On the balance sheet, debt is small relative to equity, which is the main strength cited here.

Overseas Sales Base and New Product

The company supplies its own branded products to more than 70 countries, and exports were 91.7% of sales in 2023. The Amber Dry Mill, launched in Korea in July 2026, is a product the company has pointed to as a way out of its growth stall. If business with a major North American distributor expands, the existing export base could widen further.

Technology Base for New Businesses

The national project to localize core semiconductor packaging materials runs for 54 months from July 2024 and receives government funding of KRW 2.75 billion. Its stated aim is to secure a foothold in the semiconductor glass interposer market and in PCB replacement markets for mobile and 5G and 6G devices.

Development results for ultra-low thermal expansion optical glass were also shared as part of an extreme ultraviolet inspection equipment project.

09

Bear factors

Declining Profit Margins

The operating margin fell from 10.1% in 2023 to 7.7% in 2024 and 5.4% in 2025. Operating profit declined from KRW 1.61 billion in 2023 to KRW 903 million in 2025. The company attributed the drop to higher costs from expanded new investment. The pattern of sales rising while profit falls is the main bearish point.

Losses Persist Through 2026

Operating losses of KRW 818 million in Q1 2026, KRW 615 million in Q2 and KRW 666 million in Q3 make three consecutive loss quarters. Q3 2026 sales of KRW 3.48 billion fell 27.9% year on year.

The net loss attributable to owners over the last four quarters totals KRW 896 million, and profit has not returned in any quarter since the Q4 2025 profit.

Delayed North American Talks and Cost Burden

Press reports said first-half 2026 sales fell about 6.4% from a year earlier to about KRW 7.4 billion. Delayed talks to expand business with a major North American distributor and new product development costs were reported as weighing on profitability.

Because exports are a large share of sales, delays in this channel directly affect how quickly revenue can recover.

10

Risk factors

Overseas Channels and Currency

Exports were 91.7% of sales in 2023, so dependence on overseas distribution and contract structures is high. Delayed talks with a major North American distributor could slow the recovery in sales. Currency swings and changes in local regulation are also variables that could affect the profitability of export channels.

Cost Structure and Investment Burden

The company explained that higher costs from expanded new investment drove the decline in operating profit in 2025. In 2026, new product development costs and new business projects overlapped, and losses continued.

If it takes longer for new business investment to generate earnings, the timing of profit recovery could also be pushed back.

Small Cap and Shareholder Structure

As a small-cap stock, Hass may see large swings in trading. According to the 2024 registration statement, the largest shareholder group held 38.3%, which could leave a limited free float.

In August 2026 the company agreed to a buyback trust contract worth KRW 1 billion and said the purpose was to stabilize the share price.

11

What to watch next

  1. December 31, 2026

    This is the close of fiscal 2026. Whether talks to expand business with a major North American distributor lead to a disclosed contract is the next checkpoint.

  2. End of March 2027

    This is the filing deadline for the 2026 annual report. It will show fourth-quarter sales and operating results, how the annual operating margin compares with 5.4% in 2025, and whether a dividend is resolved.

  3. May 15, 2027

    This is the filing deadline for the Q1 2027 quarterly report. The next checkpoint is whether the operating loss narrows from the KRW 818 million loss recorded in Q1 2026.

12

Overall view

Hass's annual sales rose from KRW 16 billion to KRW 16.6 billion over 2023 to 2025, but operating profit and profit attributable to owners declined over the same period. The operating margin fell from 10.1% to 5.4%, and operating losses continued for three consecutive quarters from Q1 to Q3 2026.

On the financial side, a debt ratio of 18.3% in 2025 and operating cash flow that rose to KRW 1.82 billion are the main strengths. Exports at 91.7% of sales in 2023, the Amber Dry Mill launch and the semiconductor packaging materials project are presented as growth options.

On the other side, delayed talks with a major North American distributor, new product development costs, and a net loss attributable to owners of KRW 896 million over the last four quarters are the weaknesses.

Valuation sits low relative to net assets, but no earnings-based multiple can be calculated, so asset-based and earnings-based measures point in different directions. The next checkpoints are the trend in losses in the 2026 annual report and the Q1 2027 quarterly report. This report contains no investment rating, recommendation or target price and is provided for information only.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. butler.works
  2. finuts.co.kr
  3. m.news.nate.com
  4. m.news.nate.com
  5. yakup.com
  6. eugenefn.com
  7. m.news.nate.com
  8. pharmnews.com
  9. hankyung.com
  10. tradingview.com
  11. uk.advfn.com
  12. prnewswire.com
  13. kr.investing.com
  14. m.news.nate.com
  15. eugenefn.com
  16. eugenefn.com
  17. investing.com
  18. stocktwits.com

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis